Avid welcomes Erik Tomalis and Stephen Boudreau to its leadership team, poised to transform how nonprofits approach and grow ...
Avid Bioservices, Inc. engages in the commercial manufacturing. The firm focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and ...
(RTTNews) - Avid Bioservices (CDMO), which agreed to be acquired by GHO Capital Partners and Ampersand Capital Partners last month, has announced financial results for the second quarter ended ...
TUSTIN, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development ...
TUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) ...
Avid Bioservices, Inc. has announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act regarding its planned acquisition by GHO Capital Partners and ...
RBC Capital analyst Sean Dodge maintained a Hold rating on Avid Bioservices (CDMO – Research Report) on January 8 and set a price target of ...